Literature DB >> 33214778

Sedative and Analgesic Pharmacokinetics During Pediatric ECMO.

Kanecia O Zimmerman1,2, Samantha H Dallefeld3, Christoph P Hornik1,2, Kevin M Watt4.   

Abstract

Sedatives and analgesics are often administered to critically ill children supported by extracorporeal membrane oxygenation (ECMO) to facilitate comfort and to decrease risks of life-threatening complications. Optimization of sedative and analgesic dosing is necessary to achieve desired therapeutic benefits and must consider interactions between the circuit and patient that may affect drug metabolism, clearance, and impact on target organs. This paper reviews existing in vitro and pediatric in vivo literature concerning the effects of the ECMO circuit on sedative and analgesic disposition and offers dosing guidance for the management of critically ill children receiving these drugs. Copyright Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2020.

Entities:  

Keywords:  child; deep sedation; extracorporeal membrane oxygenation; infant; newborn; pain management; pharmacokinetics

Year:  2020        PMID: 33214778      PMCID: PMC7671016          DOI: 10.5863/1551-6776-25.8.675

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  77 in total

1.  Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.

Authors:  Nilesh M Mehta; David R Halwick; Brenda L Dodson; John E Thompson; John H Arnold
Journal:  Intensive Care Med       Date:  2007-04-03       Impact factor: 17.440

2.  Off-label medication use in an academic hospital pediatric critical care unit.

Authors:  Benson Hsu; Thomas Brazelton
Journal:  WMJ       Date:  2009-10

3.  The effect of critical illness and inflammation on midazolam therapy in children.

Authors:  Nienke J Vet; Matthijs de Hoog; Dick Tibboel; Saskia N de Wildt
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

4.  In vitro variability in fentanyl absorption by different membrane oxygenators.

Authors:  D A Rosen; K R Rosen; D L Silvasi
Journal:  J Cardiothorac Anesth       Date:  1990-06

5.  COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yolanda R Smith; Joshua A Bueller; Ke Xu; Yanjun Xu; Robert A Koeppe; Christian S Stohler; David Goldman
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

6.  Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001.

Authors:  Shirley Hui-Stickle; Eileen D Brewer; Stuart L Goldstein
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

7.  Membrane oxygenator heat exchanger failure detected by unique blood gas findings.

Authors:  Justin L Hawkins
Journal:  J Extra Corpor Technol       Date:  2014-03

8.  Interaction of plasma proteins with commercial protein repellent polyvinyl chloride (PVC): a word of caution.

Authors:  F De Somer; A Van Landschoot; G Van Nooten; J Delanghe
Journal:  Perfusion       Date:  2008-07       Impact factor: 1.972

9.  Determinants of drug absorption in different ECMO circuits.

Authors:  E D Wildschut; M J Ahsman; K Allegaert; R A A Mathot; D Tibboel
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

10.  Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; Jason A Roberts; Charles I Mcdonald; Stephanie Fisquet; Adrian G Barnett; Daniel V Mullany; Sussan Ghassabian; Steven C Wallis; Yoke L Fung; Maree T Smith; John F Fraser
Journal:  Crit Care       Date:  2012-10-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.